Cristiano Fava
Cristiano Fava
professor of Internal Medicine
Verified email at
Cited by
Cited by
Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk.
C consortium, C Consortium, KG Consortium, EG consorti
Nature 478 (7367), 103-109, 2011
The genetics of blood pressure regulation and its target organs from association studies in 342,415 individuals
GB Ehret, T Ferreira, DI Chasman, AU Jackson, EM Schmidt, T Johnson, ...
Nature genetics 48 (10), 1171-1184, 2016
Genome-Wide Association Study of Blood Pressure Extremes Identifies Variant near UMOD Associated with Hypertension
S Padmanabhan, O Melander, T Johnson, AM Di Blasio, WK Lee, ...
PLoS genetics 6 (10), e1001177, 2010
Effect of CPAP on blood pressure in patients with OSA/hypopnea: a systematic review and meta-analysis
C Fava, S Dorigoni, F Dalle Vedove, E Danese, M Montagnana, GC Guidi, ...
Chest 145 (4), 762-771, 2014
Trans-ancestry meta-analyses identify rare and common variants associated with blood pressure and hypertension
P Surendran, F Drenos, R Young, H Warren, JP Cook, AK Manning, ...
Nature genetics 48 (10), 1151-1161, 2016
Obstructive sleep apnea syndrome and cardiovascular diseases
C Fava, M Montagnana, EJ Favaloro, GC Guidi, G Lippi
Seminars in thrombosis and hemostasis 37 (03), 280-297, 2011
Platelets promote thromboinflammation in SARS-CoV-2 pneumonia
F Taus, G Salvagno, S Canè, C Fava, F Mazzaferri, E Carrara, V Petrova, ...
Arteriosclerosis, thrombosis, and vascular biology 40 (12), 2975-2989, 2020
The V433M Variant of the CYP4F2 Is Associated With Ischemic Stroke in Male Swedes Beyond Its Effect on Blood Pressure
C Fava, M Montagnana, P Almgren, L Rosberg, G Lippi, B Hedblad, ...
Hypertension 52 (2), 373-380, 2008
GWAS and colocalization analyses implicate carotid intima-media thickness and carotid plaque loci in cardiovascular outcomes
N Franceschini, C Giambartolomei, PS De Vries, C Finan, JC Bis, ...
Nature communications 9 (1), 5141, 2018
Glucose and collagen regulate human platelet activity through aldose reductase induction of thromboxane
WH Tang, J Stitham, S Gleim, C Di Febbo, E Porreca, C Fava, ...
The Journal of clinical investigation 121 (11), 2011
Obstructive sleep apnoea treatment and blood pressure: which phenotypes predict a response? A systematic review and meta-analysis
MF Pengo, D Soranna, A Giontella, E Perger, P Mattaliano, EI Schwarz, ...
European Respiratory Journal 55 (5), 2020
Prediction of blood pressure changes over time and incidence of hypertension by a genetic risk score in Swedes
C Fava, M Sjögren, M Montagnana, E Danese, P Almgren, G Engström, ...
Hypertension 61 (2), 319-326, 2013
Discovery of rare variants associated with blood pressure regulation through meta-analysis of 1.3 million individuals
P Surendran, EV Feofanova, N Lahrouchi, I Ntalla, S Karthikeyan, J Cook, ...
Nature genetics 52 (12), 1314-1332, 2020
Causal effect of plasminogen activator inhibitor type 1 on coronary heart disease
C Song, S Burgess, JD Eicher, ...
Journal of the American Heart Association 6 (6), e004918, 2017
The role of red blood cell distribution width (RDW) in cardiovascular risk assessment: useful or hype?
C Fava, F Cattazzo, ZD Hu, G Lippi, M Montagnana
Annals of translational medicine 7 (20), 2019
Heritability of ambulatory and office blood pressure phenotypes in Swedish families
C Fava, P Burri, P Almgren, L Groop, UL Hulthén, O Melander
Journal of hypertension 22 (9), 1717-1721, 2004
Altered release of cytochrome p450 metabolites of arachidonic acid in renovascular disease
P Minuz, H Jiang, C Fava, L Turolo, S Tacconelli, M Ricci, P Patrignani, ...
Hypertension 51 (5), 1379-1385, 2008
The 2020 Italian Society of Arterial Hypertension (SIIA) practical guidelines for the management of primary aldosteronism
GP Rossi, V Bisogni, AV Bacca, A Belfiore, M Cesari, A Concistrè, ...
International Journal of Cardiology Hypertension 5, 100029, 2020
Atherosclerosis is an inflammatory disease which lacks a common anti-inflammatory therapy: how human genetics can help to this issue. A narrative review
C Fava, M Montagnana
Frontiers in Pharmacology 9, 55, 2018
Impact of the CYP4F2 p.V433M Polymorphism on Coumarin Dose Requirement: Systematic Review and Meta‐Analysis
E Danese, M Montagnana, JA Johnson, AE Rettie, CF Zambon, SA Lubitz, ...
Clinical Pharmacology & Therapeutics 92 (6), 746-756, 2012
The system can't perform the operation now. Try again later.
Articles 1–20